7,649.00

+35.00

+0.46%

52,174.00

+256.00

+0.49%

28,748.25

+214.25

+0.75%

Russell 2000 Futures

2,840.00

+18.70

+0.66%

4.9290

-0.0600

-1.20%

19.12

-0.30

-1.54%

3,912.00

+13.10

+0.34%

77,874.06

+125.63

+0.16%

Crude Oil Dec 26

99.70

-4.42

-4.25%

US Private Equity

10,850.63

-82.20

-0.75%

OTC Markets OTCPK - Delayed Quote USD

AB Science S.A. (ABSCF)

1.1200 0.0000 (0.00%)

At close: October 30 at 5:00:00 PM EDT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

AB Science will hold a web conference on Wednesday, October 14, 2026, from 6:00 p.m. to 7:30 p.m.

GlobeNewswire 20d ago

AB.PA
AB Science today reports its revenues for the first half of 2026 and provides an update on its activities

GlobeNewswire 23d ago

AB.PA
AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection

GlobeNewswire 1mo ago

AB.PA
AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026

GlobeNewswire 2mo ago

AB.PA
AB Science announces today the successful completion of capital increases of a total gross amount of EUR 14.2 million

GlobeNewswire 2mo ago

AB.PA
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight

PR Newswire 2mo ago

ROP.SW

ANVS

AB.PA
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire 8mo ago

ABSCF
0.00%
MNOV

TAK

Performance Overview

Return	ABSCF	CAC 40 (^FCHI)
YTD	-22.76%	-1.91%
1-Year	-11.11%	-1.57%
3-Year	-74.89%	+13.22%

Mobilize your Website

View Site in Mobile | Classic

Share by: